Skip to content

Early Neurological Deterioration in Patients With Acute Ischemic Stroke

Explore the Causes and Predictors of Early Neurological Deterioration Occurred in Patients With Acute Ischemic Stroke

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03703986
Acronym
ENDAIS
Enrollment
1200
Registered
2018-10-12
Start date
2018-11-20
Completion date
2019-01-30
Last updated
2019-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Infarction

Keywords

deterioration, risk factors, predictors

Brief summary

This study set out to explore the risk factors of early neurological deterioration (END) occurred in patients with acute ischemic stroke and to investigate the corresponding predictors.

Detailed description

END refers to the illness aggravation occurred in the early stage of stroke and often indicates a poor outcome. Some clinical scales may play an important role in its diagnoses and treatments. Across the reviewed studies, the risk factors of END, which included biochemical parameters, neuroimaging, ect. were explored incompletely and the effective predictors of END is unknown. We aimed to explore the risk factors of END and investigate the predictive value of certain scales.

Interventions

None listed

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects with acute ischemic stroke * Subjects with detailed progress notes

Exclusion criteria

* Subjects with thrombolysis therapy * Subjects with transient ischemia attach * Subjects complicated with seriously underlying diseases

Design outcomes

Primary

MeasureTime frameDescription
National Institutes of Health Stroke Scale7 daysNational Institutes of Health Stroke Scale (NIHSS) can assess the severity of stroke. The total score of NIHSS ranges from 0 to 42, with higher scores indicating better neurological function.
Canadian Neurological Scale7 daysCanadian Neurological Scale (CNS) can assess the severity of stroke as well. The total score of CNS ranges from 0 to 10, with higher scores indicating worse neurological function.

Secondary

MeasureTime frameDescription
Blood parameters7daysThe blood parameters included total cholesterol, triglyceride, low-density lipoprotein and high-density lipoprotein. The normal range of them were 3 mmol·L-1 to 5.7 mmol·L-1, 0 mmol·L-1 to 2.25 mmol·L-1, 2.6 mmol·L-1 to 4.1 mmol·L-1, 1.03 mmol·L-1 to 1.55 mmol·L-1, respectively.
Neuroimaging data7daysIntracranial stenosis was defined as ≥ 50% narrowing in any of the intracranial arteries. Multi-vessel lesions were recorded when the number of cerebral vascular stenosis was greater than 2.

Countries

China

Contacts

Primary ContactHong Cheng, MD
ch8706@hotmail.com+0086 2583674680
Backup ContactMei Sun, MD
sunmei188169@163.com+0086 18651316588

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026